Sean Murphy

CIK 1685042 · Chief Manuf, Strategy&Bus Dev. · last filed 2025-06-27

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$361.1K

Companies

4

Total Filings

17

Lifetime Open-Market Net

$317.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TLSIW Chief Manuf, Strategy&Bus Dev. 481,524 $0.75 $361.1K $157.2K 6 2025-06-27
Radius Health, Inc. (RDUS) Delisted Director 0 $30.00 $0 $0 5 2022-08-15
Poseida Therapeutics, Inc. (PSTX) Delisted Director 8,192,903 $9.50 $77.83M $160.0K 2 2020-07-15
Novan, Inc. (NOVN) Delisted Director $0.09 $0 3 2018-06-07

Recent Filings · Page 2 of 2

17 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-01-25 Radius Health, Inc. (RDUS) Delisted Grant (A) $0 EDGAR
2020-08-12 Radius Health, Inc. (RDUS) Delisted Grant (A) $0 EDGAR
2020-07-15 Poseida Therapeutics, Inc. (PSTX) Delisted Mixed +9,198,125 $160.0K EDGAR
2020-07-13 Poseida Therapeutics, Inc. (PSTX) Delisted Grant (A) $0 EDGAR
2018-06-07 Novan, Inc. (NOVN) Delisted Grant (A) $0 EDGAR
2017-06-07 Novan, Inc. (NOVN) Delisted Grant (A) $0 EDGAR
2016-09-22 Novan, Inc. (NOVN) Delisted Grant (A) $0 EDGAR
Showing 1117 of 17
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.